Generic Drug Market Opportunities in Ghana: Expired Registrations Analysis 2026
Analysis of 40 recently expired drug registrations in Ghana by September 2026, revealing high-potential generic entry points for key molecules like Amoxicillin, Ciprofloxacin, and Artemether/Lumefantrine.
A recent analysis of drug registrations in Ghana reveals 40 products with expired registrations by September 2026, predominantly in Ghana. This presents a significant opportunity for generic pharmaceutical manufacturers looking to enter or expand their footprint in the African market. These expired registrations span various therapeutic areas, with a notable concentration in anti-infectives and anti-malarials, suggesting unmet or underserved market needs that generic alternatives could address.
Identifying Core Generic Opportunities
The dataset of expired registrations provides a direct pipeline to potential generic entry points. By examining the active pharmaceutical ingredients (APIs), we can pinpoint molecules with high therapeutic importance and existing market demand. While many of the expired registrations are for herbal preparations or food items, several conventional drug products stand out.
Key molecules with expired registrations that represent strong generic opportunities include:
- Amoxicillin/Potassium Clavulanate: This broad-spectrum antibiotic combination, crucial for treating various bacterial infections, appears multiple times (e.g., CLAVUNOVA, MYCLAV, CLAVU-NOVA, LAVI-CV). Its widespread use indicates a consistent demand, making it a high-potential target for generic entry.
- Ciprofloxacin: A vital fluoroquinolone antibiotic, Ciprofloxacin (GEBECIP) is indispensable for treating a range of urinary tract, respiratory, and skin infections. The expiration of its registration opens the door for generic competition to provide more affordable access.
- Artemether/Lumefantrine: As a first-line treatment for uncomplicated P. falciparum malaria, Artemether/Lumefantrine (NOVAMETHER, POMEX) remains critically important in malaria-endemic regions like Ghana. Multiple expired registrations for this combination highlight an ongoing need for accessible and affordable anti-malarials.
- Aceclofenac/Paracetamol and Aceclofenac: Non-steroidal anti-inflammatory drugs (NSAIDs) and analgesics like Aceclofenac and its combination with Paracetamol (ACLO-P, ZULU-100) are widely used for pain and inflammation management. The expiration of these registrations offers an opportunity in a high-volume market segment.
- Amlodipine Besylate: A calcium channel blocker used for hypertension (TEVRALEX), Amlodipine is a backbone treatment in cardiovascular health. The expiry marks a chance for generic makers to support public health efforts in managing chronic diseases.
Other notable molecules include Abacavir/Lamivudine (antiretroviral), Benzathine Benzylpenicillin (antibiotic), and Betamethasone/Gentamycin/Tolnaftate combinations (topical anti-infectives/anti-inflammatories), each serving important therapeutic needs.
The Competitive Landscape: What to Consider
For generic manufacturers, the absence of an original marketing authorization holder (MAH) explicitly listed for many of these expired registrations (indicated by '—' in the 'Original Holder' column) could streamline the market entry process. This often means that the market may already be served by existing generics, or the original product may have been withdrawn. However, it also suggests that the regulatory path might be clearer, as there might be fewer direct incumbent challenges from proprietary brands immediately tied to these specific expired registrations. Nevertheless, a thorough market survey is essential to understand the current generic presence.
For products like GEBECIP 0.3% (Ciprofloxacin), ZINFORO (Ceftaroline Fosamil), and TEVRALEX (Amlodipine besylate), where an original holder is explicitly mentioned (GB PHARMA LIMITED, PFIZER SPECIALITIES LIMITED, NORTHLAND BIOSCIENCE), the original patent might have expired, or the company may have chosen not to renew the registration in Ghana. This scenario often signals a mature market ready for cost-effective generic alternatives.
The high prevalence of herbal and traditional medicines among the expired registrations (e.g., Abamata Ginger Powder, EMI CREAM, ABBOR OINTMENT, TINARQ OINTMENT, APDYL- H COUGH SYRUP, DYNAMIC HERBAL OINTMENT, MARY OYE MAAME BALM, BOAMAH OINTMENT) also indicates a dynamic and diverse pharmaceutical landscape in Ghana. While not direct generic drug opportunities in the conventional sense, these categories represent cultural and traditional preferences that could still be met with renewed or similar product offerings, subject to regulatory compliance.
Strategic Implications for Generic Manufacturers
Generic manufacturers should prioritize molecules with high public health impact and significant market demand. The concentration of expired antibiotic and anti-malarial registrations in Ghana underscores the ongoing need for these essential medicines. Focusing on these areas would not only address crucial public health needs but also offer substantial market opportunities.
Furthermore, assessing the level of competition for each molecule is vital. While a direct 'original holder' might not be visible for all expired registrations, the market for well-established generics like Amoxicillin/Clavulanate and Ciprofloxacin is likely to be competitive. However, the sheer volume of expired registrations suggests that there is room for new entrants, especially those who can navigate the local regulatory requirements efficiently and offer competitive pricing and quality.
The data from these expired registrations serves as an invaluable market intelligence tool, offering a snapshot of potential market voids and strong consumer demand. Strategic planning based on this intelligence can lead to successful product launches and market penetration for generic pharmaceutical companies in Ghana.
| Drug | Original Holder | Country | Expired |
|---|---|---|---|
| Abamata Ginger Powder(PET) (Abamata Ginger Powder(PET)) | — | Ghana | 02 Sept 2026 |
| Abamata Ginger & Garlic Powder(PET) (Abamata Ginger & Garlic Powder(PET)) | — | Ghana | 02 Sept 2026 |
| GEBECIP 0.3% (CIPROFLOXACIN) | GB PHARMA LIMITED, 65 CHATSWORTH ROAD LONDON NW2 4BG UNITED KINGDOM | Ghana | 01 Sept 2026 |
| Banquet D'or Choco Coco Cake & Banquet D'or Double Choco Dome Cake (Banquet D'or Choco Coco Cake & Banquet D'or Double Choco Dome Cake) | — | Ghana | 01 Sept 2026 |
| EMI CREAM (Betamethasone/Gentamycin /Tolnaftate/Iodochlohydroxygunoline) | — | Ghana | 01 Sept 2026 |
| ZINFORO (CETAROLINE FOSAMIL) | PFIZER SPECIALITIES LIMITESD 7TH FLOOR 21 LUGGARD V IKOYI LAGOS NIGERIA | Ghana | 01 Sept 2026 |
| AZITRO ORAL SUSPENSION (Azithromycin) | — | Ghana | 01 Sept 2026 |
| ABBOR OINTMENT (Allium sativum, Tetrapleura tetraptera, Ocimum gratissimum, Ocimum canum, Vitellaria paradoxa) | — | Ghana | 01 Sept 2026 |
| FORTIFIED PROCAINE BENZYL PENICILLIN POWDER FOR INJECTION ( 1 MEGA) (Artemether/ Lumefantrine) | — | Ghana | 01 Sept 2026 |
| TINARQ OINTMENT (Aframomum melegueta, Zingiber officinale, Paullinia pinnata, Zanthoxylum zanthoxyloides) | — | Ghana | 01 Sept 2026 |
| AMIDERM CREAM (Betamethasone Valerate/ Gentamicin Sulphate/ Tolnaftate /Clioquinol) | GB PHARMA LIMITED, 65 CHATSWORTH ROAD LONDON NW2 4BG UNITED KINGDOM | Ghana | 01 Sept 2026 |
| ESKYZOLE CREAM (Betamethasone dipropionate/Clotrimazole/Gentamicin Sulfate) | — | Ghana | 01 Sept 2026 |
| CLAVUNOVA SUSPENSION (Amoxicillin Trihydrate / Potassium Clavulanate) | — | Ghana | 01 Sept 2026 |
| CEFOSON INJECTION (CEFUROXIME) | — | Ghana | 01 Sept 2026 |
| NOVAMETHER 40/240 DS (ARTEMETHER/LUMEFANTRINE) | SKANT HEALTHCARE LIMITED 31 SHIV SAGAR ESTATE NORTH WING DR ANNIE BESANT ROAD WORLI MUMBAI 400018 INDIA | Ghana | 01 Sept 2026 |
| ABACAVIR/ LAMIVUDINE TABLETS (Each tablet contains Abacavir Sulfate/Lamivudine 600mg/300mg) (Abacavir Sulfate/Lamivudine) | — | Ghana | 01 Sept 2026 |
| TEVRALEX TABLETS (Each tablet contains Amlodipine Besylate 10mg) (Amlodipine besylate) | — | Ghana | 01 Sept 2026 |
| ARGESUN INJECTION (Each co-pack contains Artesunate/ Arginine/ Sodium bicarbonate-60mg/ 20mg/ml/ 8.4mg/ml Artesunate/ Arginine/ Sodium bicarbonate 60mg/ 20mg/ml/ 8.4mg/ml) (Artesunate/ Arginine/ Sodium bicarbonate) | — | Ghana | 01 Sept 2026 |
| SKYPARA 250mg SUPPOSITORY (Acetaminophen) | — | Ghana | 01 Sept 2026 |
| MYCLAV 625 TABLETS (Each tablet contains Amoxicillin trihydrate / Potassium clavulanate 625mg) (Amoxicillin Trihydrate / Potassium Clavulanate) | — | Ghana | 01 Sept 2026 |
| APDYL- H COUGH SYRUP (Adhatoda vasika, Glycyrrhiza glabra, Piper longum, Alpinia galanga) | — | Ghana | 01 Sept 2026 |
| VISIONOL EYE DROPS (ACARBOSE) | GB PHARMA LIMITED, 65 CHATSWORTH ROAD LONDON NW2 4BG UNITED KINGDOM | Ghana | 01 Sept 2026 |
| VICTOZA 6MG/3ML (6MG/ML) | — | Ghana | 01 Sept 2026 |
| POMEX TABLET (Artemether/Lumefantrine) | — | Ghana | 01 Sept 2026 |
| CLAVU-NOVA 625 TABLETS (Amoxicillin Sodium/Potassium Clavulanate) | — | Ghana | 01 Sept 2026 |
| TEVRALEX TABLET (Amlodipine besylate) | NORTHLAND BIOSCIENCE; 545 LANSING AVE STE 2, JACKSON, MI 49201, UNITED STATES | Ghana | 01 Sept 2026 |
| DYNAMIC HERBAL OINTMENT (Alstonia boonei, Moringa oleifera and Paullinia pinnata) | — | Ghana | 01 Sept 2026 |
| MARY OYE MAAME BALM (Allium sativum, Xylopia aethiopica and Tetrapleura tetraptera) | — | Ghana | 01 Sept 2026 |
| BLUGEL-O SUSPENSION (Each 15ml contains Aluminium Hydroxide/Magnesium Hydroxide/Oxetacaine 250mg/250mg/10mg) (Aluminium Hydroxide/Magnesium Hydroxide/Oxetacaine) | — | Ghana | 01 Sept 2026 |
| CLAVUNOVA 457MG SUSPENSION (Amoxicillin Trihydrate / Potassium Clavulanat) | — | Ghana | 01 Sept 2026 |
| POMEX TABLETS (Artemether/Lumefantrine) | — | Ghana | 01 Sept 2026 |
| BENZYLPENICILLIN INJECTION ( 1MEGA) (BENZYLPENICILLIN INJECTION ( 1MEGA)) | — | Ghana | 01 Sept 2026 |
| BENTARIX-1.2 INJECTION (Each vial contains Benzathine Benzylpenicillin 1.2G) (Benzathine Benzylpenicillin) | — | Ghana | 01 Sept 2026 |
| ACLO-P TABLETS (Each film coated tablet contains Aceclofenac / Paracetamol 100mg/ 500mg) (Aceclofenac / Paracetamol) | — | Ghana | 01 Sept 2026 |
| ZULU-100 TABLETS (Each tablet contains Aceclofenac 100mg) (Aceclofenac) | — | Ghana | 01 Sept 2026 |
| BOAMAH OINTMENT (Allium sativum, Tetrapleura tetraptera, Ocimum gratissimum, Ocimum canum, Vitellaria paradoxa) | — | Ghana | 01 Sept 2026 |
| NOVAMETHER TABLETS (Each dispersible tablet contains Artemether/ Lumefantrine – 20mg/ 120mg) (Artemether/ Lumefantrine) | — | Ghana | 01 Sept 2026 |
| LAVI-CV 625 TABLETS (Amoxicillin Trihydrate / Potassium Clavulanate) | LAVINA PHARMACEUTICALS PVT. LIMITED, SATRA PLAZA, OFFICE NO.402 PLOT NO. 19-20, SECTOR-19 D, PALM BEACH RD, NAVI MUMBAI, MAHARASHTRA 400703, INDIA | Ghana | 01 Sept 2026 |
| CLAVU-NOVA 1G TABLETS (AMOXICILLIN / CLAVULANIC) | — | Ghana | 01 Sept 2026 |
| GEBECIP TABLETS (Each film coated tablet contains Ciprofloxacin 500mg) (CIPROFLOXACIN) | — | Ghana | 01 Sept 2026 |
AfriReg Pro empowers regulatory teams by automating the tracking of market authorization expiries and renewals across African markets, providing real-time data to identify generic opportunities and manage regulatory intelligence efficiently.